Indo Us Bio Tech Limited Changes Statutory Auditor Following Resignation of Previous Firm
Indo Us Bio Tech Limited has announced a change in its Statutory Auditor. The company confirmed the resignation of M/s. Gautam N Associates, Chartered Accountants, and subsequently approved the appointment of M/s. Bhagat & Associates, Chartered Accountants, as the new auditor.M/s. Gautam N Associates tendered their resignation from the position of Statutory Auditor, effective June 15, 2026. The company stated that the reason for the change was administrative and operational restructuring of the company's audit assignments. Prior to the resignation, M/s. Gautam N Associates submitted an Independent Auditors' Report for the year ended on March 31, 2026, dated May 29, 2026.
Following the resignation, the Board of Directors approved the appointment of M/s. Bhagat & Associates, Chartered Accountants, during its meeting held on June 16, 2026. The new auditor’s term was set to commence from the date of board approval until the conclusion of the next General Meeting, subject to shareholder approval or determination in accordance with applicable company laws.
M/s. Bhagat & Associates is a firm engaged in audit, taxation, assurance and advisory services, holding FRN: 101100W. The relationship between M/s. Bhagat & Associates and the Directors of Indo Us Bio Tech Limited was noted as Not Applicable.
Key details regarding the statutory auditor transition are summarized below:
| Particular | Previous Auditor (M/s. Gautam N Associates) | New Auditor (M/s. Bhagat & Associates) |
|---|---|---|
| Resignation Date | June 15, 2026 | N/A |
| Reason for Change | Administrative and operational restructuring of the Company's audit assignments | Appointment due to resignation of previous Statutory Auditor |
| Appointment/Resignation Effective Date | September 30, 2020 (Initial appointment) / Resigned June 15, 2026 | Approved by Board on June 16, 2026 |
| Profile | Chartered Accountants | Engaged in audit, taxation, assurance and advisory services |
INDOUS Stock Price Movement
Today, shares of Indo Us Biotech Limited shed 3.17% in post-market trading, settling at ₹87.04. The equity saw a significant pullback as it approached the lower band, trading off an intraday low of ₹86.11 with 30,319 shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.